LCLuc de Chaisemartin

Luc de Chaisemartin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Luc de Chaisemartin has a total of 221 co-authors. Here are the top co-authors by number of shared publications:

  • Aurélie Gouel-Chéron

    Université Paris Cité, Paris, France; Anaesthesiology and Critical Care Medicine Department, DMU PARABOL, Bichat - Claude Bernard Hospital, AP-HP, Paris, France; Antibody in Therapy and Pathology, UMR 1222 INSERM, Pasteur Institute, Paris, France

    7 shared publications
  • Vanessa Granger

    Assistance Publique–Hôpitaux de Paris (AP-HP), Department of Immunology, Bichat Hospital

    7 shared publications
  • Sylvie Chollet-Martin

    Assistance Publique–Hôpitaux de Paris (AP-HP), Department of Immunology, Bichat Hospital

    6 shared publications
  • Sylvie Chollet-Martin

    INSERM UMR 996

    6 shared publications
  • Catherine Neukirch

    Service De Pneumologie, Allergologie, and Transplantation, Hôpital Bichat-Claude Bernard, Paris, France; INSERM UMR1149, Team InnaLung, Université Paris Cité, Paris, France

    5 shared publications
  • Friederike Jönsson

    Institut Pasteur, Université Paris Cité, Inserm UMR1222, Antibodies in Therapy and Pathology, 75015 Paris, France

    5 shared publications

Latest Publications

  • Severe allergic transfusion reactions to group B/AB plasma or platelets in group O recipients are linked to α-Gal sensitization

    by Luc de Chaisemartin, Virginie de la Taille, Pascale Nicaise-Roland, Lucile Malard, Cléo Beuscart, Aurélie Gouel-Chéron, Syria Laperche, Pierre Tiberghien

    Allergic transfusion reactions (ATR) are potentially lethal adverse events that occur in ∼0.3% to 6% of plasma or platelet transfusions. The main mechanism described is an immunoglobulin E (IgE)–mediated response to donor proteins, such as IgA and haptoglobin in deficient patients. Recently, in a nationwide retrospective observational study, we reported that group O recipients of group B or AB platelet concentrates or plasma were at significantly higher risk of severe ATR than recipients with other ABO combinations. Given the antigenic proximity between group B determinant and the galactose-α-1,3-galactose (α-Gal) epitope, we hypothesize a role for α-Gal IgE–mediated sensitization in these ATR. In this report, we investigated the presence of anti–α-Gal IgE in a cohort of 59 patients with severe ATR. We found that group O recipients of group B or AB blood components (plasma or platelet concentrates) were substantially more likely to exhibit high titers of group B cross-reactive anti–α-Gal IgE than other patients, supporting our hypothesis that α-Gal sensitization underlies these severe ATR. These findings suggest that α-Gal sensitization is an additional mechanism responsible for ATR in major ABO-incompatible transfusion and should be systematically explored in group O patients having received group B/AB plasma or platelets.


  • The aetiology of recurrent perioperative hypersensitivity reactions in a large French cohort

    by Khalif Bouaita, Catherine Neukirch, Simon Aubert, Pascale Roland-Nicaise, Philippe Montravers, Luc de Chaisemartin, Aurélie Gouel-Chéron

  • Open Access

    Physiopathologie des réactions anaphylactiques périopératoires

    by Aurélie Gouel-Chéron, Luc de Chaisemartin

  • Open Access

    Cytosolic proliferating cell nuclear antigen (PCNA) orchestrates neutrophil hyperactivation in COVID-19

    by Rodrigo de Oliveira Formiga, Lucie Pesenti, François Chable de la Héronnière, Maha Zohra Ladjemi, Darko Stojkov, Shida Yousefi, Philippe Frachet, Lisa Krafft, Laura Tiberio, Daniela Bosisio, et al.

    Neutrophils are central mediators of the hyperinflammatory response in severe SARS-CoV-2 infection. We report elevated cytosolic levels of proliferating cell nuclear antigen (PCNA) in neutrophils from patients with severe and critical COVID-19, correlating with enhanced NADPH oxidase–dependent reactive oxygen species (ROS) generation and neutrophil extracellular trap (NET) formation. Using T2AA, a small-molecule inhibitor of the PCNA scaffold, we demonstrate potent suppression of NADPH oxidase activation and NET release, particularly in response to SARS-CoV-2 RNA. Mechanistically, we identify a previously unrecognized interaction between PCNA and the heterodimeric S100A8/S100A9 (calprotectin), predominantly enriched in CD16 high CD62L low neutrophils expanded during COVID-19. PCNA binds the dimeric S100A8/S100A9 complex mediated via S100A8 subunit with micromolar affinity, and this interaction is abrogated by tetramerization, suggesting regulation by intracellular calcium. Disruption of this complex by T2AA inhibited ROS production in an S100A8/S100A9-dependent manner, implicating calprotectin as a functional regulator of neutrophil activation. In a betacoronavirus mouse model, T2AA treatment attenuated lung inflammation, reduced NET and calprotectin levels, and shifted pulmonary neutrophils away from hyperactivated and immunosuppressive phenotypes, consistent with immune reprogramming toward resolution. These findings establish cytosolic PCNA as a central scaffold in neutrophil hyperactivation during COVID-19 and highlight its pharmacological disruption as a promising host-directed strategy to limit inflammation and prevent organ damage.

  • Open Access

    Decrease in Eosinophil‐Derived‐Neurotoxin With Mepolizumab Is Associated With Asthma Improvement

    by Vanessa Granger, Rachel Nadif, Laurent Orsi, Sylvie Chollet Martin, Luc de Chaisemartin, Camille Taillé


  • Deep phenotyping of human neutrophils in whole blood using a 33-color spectral flow cytometry panel

    by Vanessa Krémer, Marion Rambault, Sandrine Schmutz, Nicolas Montcuquet, Pierre Bruhns, Luc de Chaisemartin, Friederike Jönsson

    Neutrophils are the most abundant leukocytes in the circulation and critical players in host defense and inflammation. They respond rapidly to numerous biological, chemical, and physical stimuli, making it challenging to characterize their steady-state phenotypes, activation states, and subsets in an unbiased and precise manner. To address this problem, we designed a 33-color spectral flow cytometry panel for the deep profiling of unprocessed neutrophils in human blood. This panel allows the profiling of neutrophil phenotypes related to activation, immune modulation, granule release, ontogeny, phagocytic capacity, and migration, in addition to monitoring all major human leukocyte populations. We validated the panel using whole blood stimulations that induce distinct phenotypic shifts in the neutrophil population. This optimized spectral flow cytometry panel allows comprehensive immune profiling of the functional heterogeneity of human blood neutrophils and is suitable for longitudinal or exploratory analysis of neutrophil dynamics and activation states in clinical cohorts.


  • Rocuronium-specific antibodies drive perioperative anaphylaxis but can also function as reversal agents in preclinical models

    by Alice Dejoux, Qianqian Zhu, Christelle Ganneau, Odile Richard-Le Goff, Ophélie Godon, Julien Lemaitre, Francis Relouzat, François Huetz, Aurélien Sokal, Alexis Vandenberghe, et al.

    Neuromuscular blocking agents (NMBAs) relax skeletal muscles to facilitate surgeries and ease intubation but can lead to adverse reactions, including complications because of postoperative residual neuromuscular blockade (rNMB) and, in rare cases, anaphylaxis. Both adverse reactions vary between types of NMBAs, with rocuronium, a widely used nondepolarizing NMBA, inducing one of the longest rNMB durations and highest anaphylaxis incidences. rNMB induced by rocuronium can be reversed by the synthetic γ-cyclodextrin sugammadex. However, in rare cases, sugammadex can provoke anaphylaxis. Thus, additional therapeutic options are needed. Rocuronium-induced anaphylaxis is proposed to rely on preexisting rocuronium-binding antibodies. To understand the pathogenesis of rocuronium-induced anaphylaxis and to identify potential therapeutics, we investigated the memory B cell antibody repertoire of patients with suspected hypersensitivity to rocuronium. We identified polyclonal antibody repertoires with a high diversity among V(D)J genes without evidence of clonal groups. When recombinantly expressed, these antibodies demonstrated specificity and low affinity for rocuronium without cross-reactivity for other NMBAs. Moreover, when these antibodies were expressed as human immunoglobulin E (IgE), they triggered human mast cell activation and passive systemic anaphylaxis in transgenic mice, although their affinities were insufficient to serve as reversal agents. Rocuronium-specific, high-affinity antibodies were thus isolated from rocuronium-immunized mice. The highest-affinity antibody was able to reverse rocuronium-induced neuromuscular blockade in nonhuman primates with kinetics comparable to that of sugammadex. Together, these data support the hypothesis that antibodies cause anaphylactic reactions to rocuronium and pave the way for improved diagnostics and neuromuscular blockade reversal agents.


  • Are changes in antibiotic prophylaxis recommendations responsible for an increased risk of cefazolin allergy?

    by Nicolas Chéron, Luc de Chaisemartin, Simon Aubert, Felix Laborier, Philippe Montravers, Catherine Neukirch, Aurélie Gouel-Chéron


  • Open Access

    Circulating microbiome analysis in patients with perioperative anaphylaxis

    by Luc de Chaisemartin, Dragos Ciocan, Aurélie Gouel-Chéron, Vanessa Granger, Dan Longrois, Philippe Montravers, Anne-Marie Cassard, Sylvie Chollet-Martin

    Background: Perioperative anaphylaxis is a rare and acute systemic manifestation of drug-induced hypersensitivity reactions that occurs following anesthesia induction; the two main classes of drugs responsible for these reactions being neuromuscular blocking agents (NMBA) and antibiotics. The sensitization mechanisms to the drugs are not precisely known, and few risk factors have been described. A growing body of evidence underlines a link between occurrence of allergy and microbiota composition. However, no data exist on microbiota in perioperative anaphylaxis. The aim of this study was to compare circulating microbiota richness and composition between perioperative anaphylaxis patients and matched controls.Methods: Circulating 16s rDNA was quantified and sequenced in serum samples from 20 individuals with fully characterized IgE-mediated NMBA-related anaphylaxis and 20 controls matched on sex, age, NMBA received, type of surgery and infectious status. Microbiota composition was analyzed with a published bioinformatic pipeline and links with patients clinical and biological data investigated.Results: Analysis of microbiota diversity showed that anaphylaxis patients seem to have a richer circulating microbiota than controls, but no major differences of composition could be detected with global diversity indexes. Pairwise comparison showed a difference in relative abundance between patients and controls for Saprospiraceae, Enterobacteriaceae, Veillonellaceae, Escherichia-Shigella, Pseudarcicella, Rhodoferax, and Lewinella. Some taxa were associated with concentrations of mast cell tryptase and specific IgE.Conclusion: We did not find a global difference in terms of microbiota composition between anaphylaxis patient and controls. However, several taxa were associated with anaphylaxis patients and with their biological data. These findings must be further confirmed in different settings to broaden our understanding of drug anaphylaxis pathophysiology and identify predisposition markers.


  • Open Access

    Isolation methods determine human neutrophil responses after stimulation

    by Vanessa Krémer, Ophélie Godon, Pierre Bruhns, Friederike Jönsson, Luc de Chaisemartin

    Studying neutrophils is challenging due to their limited lifespan, inability to proliferate, and resistance to genetic manipulation. Neutrophils can sense various cues, making them susceptible to activation by blood collection techniques, storage conditions, RBC lysis, and the isolation procedure itself. Here we assessed the impact of the five most used methods for neutrophil isolation on neutrophil yield, purity, activation status and responsiveness. We monitored surface markers, reactive oxygen species production, and DNA release as a surrogate for neutrophil extracellular trap (NET) formation. Our results show that neutrophils isolated by negative immunomagnetic selection and density gradient methods, without RBC lysis, resembled untouched neutrophils in whole blood. They were also less activated and more responsive to milder stimuli in functional assays compared to neutrophils obtained using density gradients requiring RBC lysis. Our study highlights the importance of selecting the appropriate method for studying neutrophils, and underscores the need for standardizing isolation protocols to facilitate neutrophil subset characterization and inter-study comparisons.